康基医疗(09997)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09997 康基医疗

停牌 02-16 12:00:00

9.200

+0.000

0.00%

最高9.200	最低9.200	成交量0.00
今开9.200	昨收9.200	日振幅0.00%
总市值111.14亿	流通市值111.14亿	总股本12.08亿
成交额0.00	换手率0.00%	流通股本12.08亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09997","market":"HK","secType":"STK","nameCN":"康基医疗","latestPrice":9.2,"timestamp":1771214400000,"preClose":9.2,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":1208000000,"shares":1208000000,"eps":0.494525,"marketStatus":"停牌","change":0,"latestTime":"02-16 12:00:00","open":9.2,"high":9.2,"low":9.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.51,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771551000000},"marketStatusCode":6,"adr":0,"listingDate":1593360000000,"exchange":"SEHK","adjPreClose":9.2,"dividendRate":0.029511,"openAndCloseTimeList":[[1771205400000,1771214400000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09997/tweets","defaultTab":"tweets","newsList":[{"id":"2611170422","title":"港股异动 | 微创心通-B(02160)涨超6% 植入式心律转复除颤器进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2611170422","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611170422?lang=zh_cn&edition=full","pubTime":"2026-02-16 11:27","pubTimestamp":1771212433,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创心通-B涨超6%，截至发稿，涨6.33%，报0.84港元，成交额859.92万港元。消息面上，2月13日晚，微创心通发布公告称，近日，国家药品监督管理局“NMPA”医疗器械技术审评中心发布《创新医疗器械特别审查申请审查结果公示》，拟同意集团旗下新一代植入式心律转复除颤器TILEN/EYLEN 进入创新医疗器械特别审查程序。据此 ，TILEN/EYLEN有望成为国内首款获批的具备自主知识产权的磁共振条件安全ICD。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405665.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1222","09997","BK4585","VXUS","02160","BK1574","BK1100","VT","BK4588","BK1583","09996","159883"],"gpt_icon":0},{"id":"2611651851","title":"微创心通-B(02160)：植入式心律转复除颤器进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2611651851","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611651851?lang=zh_cn&edition=full","pubTime":"2026-02-13 23:03","pubTimestamp":1770994990,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创心通-B 发布公告，近日，国家药品监督管理局“NMPA”医疗器械技术审评中心发布《创新医疗器械特别审查申请审查结果公示》，拟同意集团旗下新一代植入式心律转复除颤器TILEN/EYLEN 进入创新医疗器械特别审查程序。此次TILEN/EYLEN进入NMPA绿色通道，有望加速磁共振条件安全ICD的国产化进程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","159883","09997","BK1222","BK1574","09996","02160","BK1100"],"gpt_icon":0},{"id":"2611813478","title":"中生北控生物科技(08247)附属中生医疗自主研发的BioCyte 系列流式细胞仪获发马来西亚医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2611813478","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611813478?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:43","pubTimestamp":1770972201,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中生北控生物科技 发布公告，本公司的附属公司中生(苏州)医疗科技有限公司自主研发的BioCyte 系列流式细胞仪，近日成功通过马来西亚医疗器械管理局的审核，正式获得马来西亚医疗器械注册证，注册编号为IVDA9463526–225393。BioCyte系列流式细胞仪凭藉稳定性能及检测准确性，已在国内市场获得应用。中生医疗依据当地相关法规要求，完成产品检测、技术资料提交及审核程式，最终获得马来西亚医疗器械管理局批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","159891","09997","BK1583","BK1100","159883","08247","BK1222","09996","BK1161"],"gpt_icon":0},{"id":"2611313360","title":"心力衰竭医疗器械开发商BioVentrix(BVXX.US)申请在美IPO 拟募资1700万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611313360","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611313360?lang=zh_cn&edition=full","pubTime":"2026-02-13 14:57","pubTimestamp":1770965856,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于研发心力衰竭微创治疗技术的医疗器械公司BioVentrix于周四向美国证券交易委员会提交申请，拟通过首次公开募股筹集至多1700万美元资金。BioVentrix是一家研发并商业化用于治疗射血分数降低型心力衰竭的医疗器械公司。BioVentrix此前曾通过销售Revivent TC经导管心室增强系统获得收入，该产品已于2023年停止销售以节约资金。BioVentrix已于2025年8月5日秘密提交上市申请。本次IPO由The Benchmark Company独家担任账簿管理人，暂未披露发行定价条款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1574","BK1222","09996","BK1100","BK1583","09997"],"gpt_icon":0},{"id":"2610993374","title":"港股概念追踪|AI有望赋能手术机器人实现自主操作  机构看好产业链企业估值提升（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2610993374","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610993374?lang=zh_cn&edition=full","pubTime":"2026-02-12 08:25","pubTimestamp":1770855944,"startTime":"0","endTime":"0","summary":"渗透率提升等拉动下，手术机器人市场空间巨大，行业高增长可期。该行认为，收费目录若落地或将加速手术机器人入院，腔镜与骨科手术机器人在2026年或将步入快速发展期。看好2026年收费目录落地以及出海加速催化下国产手术机器人的放量拐点，看好具有商业化能力的手术机器人平台型企业以及上游厂商。中信建投认为，AI有望赋能手术机器人实现自主操作，进一步辅助或替代医生的部分手术操作流程，利好行业渗透率和相关公司估值提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02252","02675","BK4585","BK1222","BK4588","VT","BK1617","VXUS","BK1100","BK1583","09997"],"gpt_icon":0},{"id":"2610073856","title":"创新放量，交易升温！中国创新医疗器械发展迈入新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2610073856","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610073856?lang=zh_cn&edition=full","pubTime":"2026-02-11 09:54","pubTimestamp":1770774857,"startTime":"0","endTime":"0","summary":"在国家的大力支持下，我国创新医疗器械在近年来发展正突飞猛进。此外，2025年国家药监局公告进入创新医疗器械特别审查程序的产品数量也已高达122款，相比2024年接近翻倍。值得一提的是，随着国产医疗器械创新能力的不断提升，近两年来，中国创新医疗器械收购交易也正逐渐起势。总的来说，中国创新医疗器械产业正处在由大向强转变、换道超车的重要关口期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211095929a495c7e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211095929a495c7e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02190","09997","BK1574","BK1222","BK1587","09996","BK1583"],"gpt_icon":0},{"id":"2610832633","title":"广西北海市开展春节前医疗器械监督检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2610832633","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610832633?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:51","pubTimestamp":1770627060,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 春节将至，为切实保障群众节日期间用械安全，规范医疗器械市场秩序，近日，广西北海市市场监管部门开展春节前医疗器械质量安全监督检查行动，以强监管、严排查、守底线，守护群众健康过年。行动中，北海市市场监管部门坚持监管与服务并重，推动形成闭环管理。下一步，北海市市场监管部门将持续强化动态巡查，畅通投诉举报渠道，全力守护群众春节期间用械安全，保障人民群众度过平安祥和的新春佳节。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-09/doc-inhmfivm6305424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1222","09997","BK1100","BK1583","09996","159883"],"gpt_icon":0},{"id":"2610800226","title":"九强生物最新公告：取得纤维蛋白（原）降解产物测定试剂盒医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2610800226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610800226?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:43","pubTimestamp":1770626583,"startTime":"0","endTime":"0","summary":"九强生物公告称，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品为纤维蛋白（原）降解产物测定试剂盒，注册证编号为京械注准20262400041，注册类别为Ⅱ类，有效期至2031年2月4日。该试剂盒用于体外定量检测人血浆中的纤维蛋白（原）降解产物含量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900020612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0012","300406","09996","BK1100","BK1574","BK1583","BK0077","09997","BK1222","159883","BK0239"],"gpt_icon":0},{"id":"2610027405","title":"海南自贸港医疗器械保税维修业务 首次实现全流程闭环","url":"https://stock-news.laohu8.com/highlight/detail?id=2610027405","media":"海口网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610027405?lang=zh_cn&edition=full","pubTime":"2026-02-09 10:31","pubTimestamp":1770604260,"startTime":"0","endTime":"0","summary":"记者从海口海关获悉，近日，首批适用“执行例外措施”政策的区外保税维修货物已在海口国家高新区完成全部维修流程，并从海口美兰机场口岸复运出境，这标志着海南自贸港医疗器械保税维修业务首次实现“进口—维修—复运出境”全流程闭环。该项目允许企业在海关全程监管下，接收来自全球的自产待修医疗器械设备，开展检测、维修及功能升级服务，维修完成后直接复运出境。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-09/doc-inhmesxq2352301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","BK1574","159883","BK1222","BK1583","BK1100","09997"],"gpt_icon":0},{"id":"2609526452","title":"开年两标 | 合景建设中标马来西亚医疗器械GMP洁净工程项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2609526452","media":"PCBworld","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609526452?lang=zh_cn&edition=full","pubTime":"2026-02-07 11:03","pubTimestamp":1770433408,"startTime":"0","endTime":"0","summary":"—— 2026 ——中标喜讯精益建设，以品质筑非凡2026年合景建设华章再启开年首月连中两标2月4日合景建设旗下海外公司洲际建设（马来西亚）有限公司成功中标国家重点高新技术企业新三板上市公司某医疗器械公司马来西亚新山工程项目续写中国工程企业在海外高端制造业建设领域的崭新篇章合景建设以“中国智慧”对话“全球市场”以“品质工程”服务“信任托付”助力制造业发展该公司是一家专注于临床医疗设备研发与制造的上","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020712480895403a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020712480895403a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03913","BK1229","09996","BK1258","BK1574","BK1583","BK1542","BK1222","09997","BK1100"],"gpt_icon":0},{"id":"2609020536","title":"【券商聚焦】中泰国际：政策继续支持高品质创新药与高端医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2609020536","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609020536?lang=zh_cn&edition=full","pubTime":"2026-02-06 08:40","pubTimestamp":1770338454,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际发布医药行业2月投资策略，生医疗保健指数1月上涨8.6%，跑赢恒生指数1.7个百分点，主因：1)CXO板块多家企业发布盈喜预告，推动股价上涨。3)国家医保局发布政策支持高品质手术机器人获溢价，医疗器械板块中相关个股上涨。该机构指，国家药监局继续支持高品质创新药发展。中国生物制药本身在肝病、自免、呼吸、肿瘤等领域已有丰富布局，本次通过收购将夯实心血管领域的竞争力。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974664","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LU0052750758.USD","LU0348825331.USD","LU0359201612.USD","LU2045819591.USD","SG9999002463.SGD","LU0708995583.HKD","02269","BK1191","01177","HK0000165453.HKD","LU0140636845.USD","LU0039217434.USD","LU1242518857.USD","LU0348735423.USD","LU0572944931.SGD","BK1610","BK1222","09996","LU0417516738.SGD","BK1515","03696","LU0327786744.USD","BK1576","LU0456846285.SGD","IE00BZ08YS42.EUR","LU0456827905.SGD","IE00BZ08YT58.USD","159883","LU0043850808.USD","09997","LU0516423091.SGD","LU2125910500.SGD","LU0320764599.SGD","SG9999002562.SGD","LU0326950275.SGD","LU0516423174.USD","LU0516422440.USD","IE00B0JY6N72.USD","LU0823426308.USD","159992","BK1574","LU0516422952.EUR","LU2039709279.SGD","LU0181495838.USD","LU0359202008.SGD","LU0516422366.SGD","LU0823426480.USD","LU0307460666.USD","02359"],"gpt_icon":0},{"id":"2609309787","title":"明德生物（002932）披露增资并收购蓝怡（湖南）医疗器械有限公司股权进展公告，2月5日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309787","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309787?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:33","pubTimestamp":1770301993,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，明德生物报收于19.26元，较前一交易日上涨0.21%，最新总市值为44.78亿元。公告显示，公司于2026年1月19日召开第五届董事会第三次会议，审议通过增资并收购蓝怡（湖南）医疗器械有限公司股权的议案。截至本公告日，湖南蓝怡已完成工商变更登记，公司持有其51%股权，湖南蓝怡成为公司控股子公司，纳入合并报表范围。嘉善禾欣咨询管理合伙企业受让蓝怡集团持有的湖南蓝怡20%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0239","09997","BK1100","159883","002932","BK1574","BK1222","09996"],"gpt_icon":0},{"id":"2609309733","title":"陇神戎发（300534）披露取得《医疗器械生产许可证》公告，2月5日股价下跌1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309733?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:27","pubTimestamp":1770301637,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，陇神戎发报收于10.21元，较前一交易日下跌1.64%，最新总市值为30.97亿元。陇神戎发于2026年2月5日发布《关于取得〈医疗器械生产许可证〉的公告》。公告显示，公司于2026年2月5日取得甘肃省药品监督管理局核发的《医疗器械生产许可证》，许可证编号为甘药监械生产许20260001号，生产范围为Ⅲ类：10-04-血液净化及腹膜透析器具，许可期限自2026年2月4日至2031年2月3日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","159883","BK1222","BK1583","BK1574","300534","BK0056","09997","BK0132","BK0239","BK1100"],"gpt_icon":0},{"id":"2609060093","title":"三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证公告，2月5日股价上涨1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609060093","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609060093?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:17","pubTimestamp":1770301035,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，三鑫医疗报收于9.43元，较前一交易日上涨1.18%，最新总市值为49.23亿元。该股当日开盘9.28元，最高9.6元，最低9.26元，成交额达9887.11万元，换手率为2.9%。近日，三鑫医疗披露《关于控股子公司变更医疗器械生产许可证的公告》。公告显示，公司控股子公司成都威力生生物科技有限公司因生产经营需要，对其《医疗器械生产许可证》的生产地址进行了变更，并取得四川省药品监督管理局换发的新证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0251","09997","BK1583","BK1100","159883","BK1222","300453","09996"],"gpt_icon":0},{"id":"2609632216","title":"陇神戎发(300534.SZ)取得一项医疗器械生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2609632216","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609632216?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:41","pubTimestamp":1770280906,"startTime":"0","endTime":"0","summary":"智通财经APP讯，陇神戎发(300534.SZ)公告，公司取得由甘肃省药品监督管理局核发的《医疗器械生产许可证》，本次取得《医疗器械生产许可证》标志着公司血液透析浓缩液(干粉)产品具备生产和上市销售的资质。血液透析浓缩液(干粉)作为血液透析类医疗器械，用于急性肾衰竭、慢性肾衰竭的血液透析治疗，已经被临床广泛应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","159883","BK1583","BK1574","BK0132","09997","BK1222","300534","BK0239","BK0056","BK1100"],"gpt_icon":0},{"id":"2609341181","title":"海南自贸港医疗器械保税维修业务实现全流程闭环","url":"https://stock-news.laohu8.com/highlight/detail?id=2609341181","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609341181?lang=zh_cn&edition=full","pubTime":"2026-02-05 11:52","pubTimestamp":1770263520,"startTime":"0","endTime":"0","summary":"海口海关5日披露，首批适用“执行例外措施”政策的区外保税维修货物近日在海口国家高新区完成全部维修流程，从海口美兰机场口岸复运出境。这标志着海南自贸港医疗器械保税维修业务首次实现“进口—维修—复运出境”全流程闭环。海口海关表示，下一步将推动医疗器械、航空器材、精密仪器等高端保税维修业态在琼集聚发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-02-05/doc-inhktspr3090560.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-05/doc-inhktspr3090560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","BK1574","159883","BK1100","09997","BK1222","BK1583"],"gpt_icon":0},{"id":"2608362077","title":"复星医药：公司直接运营的业务覆盖制药、医疗器械及医学诊断、医疗健康服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2608362077","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608362077?lang=zh_cn&edition=full","pubTime":"2026-02-04 21:37","pubTimestamp":1770212245,"startTime":"0","endTime":"0","summary":"证券日报网讯2月4日，复星医药在互动平台回答投资者提问时表示，公司自1994年创立于上海，是一家植根中国、创新驱动的全球化医药健康产业集团。目前，公司直接运营的业务覆盖制药、医疗器械及医学诊断、医疗健康服务；其中，制药是公司的核心主营业务，也是公司品牌建设的重要承载。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602043641720167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","159760","XBI","BK0187","BK0188","BK0096","BK0012","BK1583","BK0175","XLV","LABU","BK0239","BK4588","BK0028","01477","BK0060","BK4585","BK0196","BK0183","BK1593","159883","BK1222","09997","09996","02196","BK1574","600196","BK1100","BK1191","BK4581"],"gpt_icon":0},{"id":"2608359486","title":"心脉医疗(688016.SH)子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2608359486","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608359486?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:47","pubTimestamp":1770194847,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心脉医疗(688016.SH)发布公告，近日，公司的全资子公司上海拓脉医疗科技有限公司(简称“拓脉医疗”)获得国家药品监督管理局颁发的关于聚乙烯醇栓塞微球的医疗器械注册证。该产品适用于富血管型实质性器官恶性肿瘤的栓塞治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","159883","09997","BK1222","BK1574","09996","BK0251","688016","BK1100"],"gpt_icon":0},{"id":"2608356852","title":"红日药业：公司业务布局可大致分为中药配方颗粒、成品药、医疗器械、原辅料、医疗健康服务和药械智慧供应链","url":"https://stock-news.laohu8.com/highlight/detail?id=2608356852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608356852?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:12","pubTimestamp":1770192736,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业02月04日在投资者关系平台上答复投资者关心的问题。公司在巩固核心产品市场地位的同时，积极推动配方颗粒业务提质增效，以应对集采政策影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400025235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","159883","BK0188","300026","BK0077","BK1222","159760","BK0239","BK1583","BK1100","09997"],"gpt_icon":0},{"id":"2608355389","title":"山东省泰安市泰山区市场监管局扎实开展医疗器械专项抽检工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2608355389","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608355389?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:36","pubTimestamp":1770190560,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯近日，泰山区市场监管局紧扣问题导向、靶向监管原则，全面启动2026年第一轮医疗器械省级专项抽检工作。下一步，泰山区市场监管局将持续深化医疗器械精准监管模式，充分发挥监督抽检的技术支撑和风险预警作用，加大对重点领域、重点主体的常态化监管力度，筑牢医疗器械质量安全防线，切实保障人民群众用械安全、有效、放心。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-04/doc-inhkrtwm6639711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","BK1574","159883","BK1100","09997","BK1222","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hzkangji.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0538},{"period":"1year","weight":0.5789},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0187},{"period":"6month","weight":0.0513},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0365}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康基医疗控股有限公司是一家主要从事微创外科手术器械及配件的设计、开发、制造及销售业务的投资控股公司。该公司的一次性产品包括一次性套管穿刺器、高分子结扎夹、一次性电凝钳、超声切割止血刀及其他一次性产品。重复性产品包括4K内窥镜摄像系统和其他重复性产品。该公司的产品应用于妇产科、泌尿外科、普通外科和胸外科等领域。该公司还提供投资咨询服务。该公司产品销往国内市场及海外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.033993},{"month":2,"riseRate":0.6,"avgChangeRate":0.022159},{"month":3,"riseRate":0.4,"avgChangeRate":-0.018922},{"month":4,"riseRate":0.8,"avgChangeRate":0.100121},{"month":5,"riseRate":0.6,"avgChangeRate":0.009096},{"month":6,"riseRate":0.2,"avgChangeRate":-0.008486},{"month":7,"riseRate":0.5,"avgChangeRate":-0.023464},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.060866},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.058003},{"month":10,"riseRate":0.5,"avgChangeRate":0.001037},{"month":11,"riseRate":0.666667,"avgChangeRate":0.032731},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.02268}],"exchange":"SEHK","name":"康基医疗","nameEN":"KANGJI MEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康基医疗(09997)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康基医疗(09997)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康基医疗,09997,康基医疗股票,康基医疗股票老虎,康基医疗股票老虎国际,康基医疗行情,康基医疗股票行情,康基医疗股价,康基医疗股市,康基医疗股票价格,康基医疗股票交易,康基医疗股票购买,康基医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康基医疗(09997)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康基医疗(09997)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}